BIOHLDG - BIOALPHA HOLDINGS BERHAD (0179.MY) : Company Factsheet (Quotes, News, Fundamentals)

Top Counters
Name	Last	Change
Tritech	0.027	+0.004
Koh Eco	0.069	+0.012
Raffles Edu	0.070	+0.011
Vividthree	0.070	+0.025
Boldtek	0.117	+0.008
GKE	0.146	+0.007
Zhongxin Fruit	0.052	+0.007
ThaiBev	0.730	+0.015
Progen	0.054	+0.003
Sunrise Shares	0.089	+0.006

World Indices
Name	Last	Change
Nasdaq	15,235.7	+9.0
HSI	25,569.0	-469.2
HSCEI	9,075.4	-184.0
Jakarta	6,605.4	-51.5
Nikkei 225	29,098.2	-7.8
SSE Comp	3,556.5	-41.2
Shanghai A	3,727.3	-43.2
Shanghai B	276.0	-1.3
KOSPI	3,026.2	-22.9

Latest News

13 Sep 2021 00:00

BIOHLDG: Changes in Director's Interest (Section 219 of CA 2016) - DATO' NORHALIM BIN YUNUS Source: Bursa Link

Key Statistics

EPS (MYR) ^a	-0.03468	Trailing EPS (MYR) ^e	-0.01744	NAV (MYR) ^b	0.1590
PE ^a	-	Trailing PE ^f	-	Price / NAV ^b	1.2579
Dividend (MYR) ^d	-	Cash In Hand (MYR) ^g	0.0361	Issued & Paid-up Shares ^c	1,186,502,220
Dividend Yield (%) ^d	-	Price / Cash In Hand ^g	5.540	Treasury Shares ^h	-
Beta - 75 Daysⁱ	0.458	R-Squared - 75 Days(%)ⁱ	1.93	Market Cap (M)	237.300
Beta - 500 Daysⁱ	1.426	R-Squared - 500 Days (%)ⁱ	7.08	Enterprise Value (M)	207.271
Piotroski F Score	1	Exchange Code	0179	Par Value ( $ )	0.05000
52 Weeks Volatility (%)	44.45	6-Month VWAP	0.218	Free Float (%)	58.3
Shariah Compliant Stocks			Yes
Sector & Industry			Health Technology - Pharmaceuticals: Major
Index Components			Bursa Malaysia Consumer Products Index

Notes:

Based on latest Full Year results announcement, adjusted for the current number of shares.
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 10 Sep 2021.Please click here for more information.
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
Based on Trailing EPS.
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
Rounded to the nearest thousand. Updated on 10 Sep 2021.
Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type	Name	Market	Market Cap (M)^a	PE ^b	Trailing PE ^c	Price / NAV ^d	Dividend Yield (%)^d
Reference	BIOHLDG	Bursa	237.300	-	-	1.2579	-
Industry	FOOD& BEVERAGES	Bursa	2,267.384	32.220	28.791	2.5892	1.832
Industry	Pharmaceuticals: Major	Bursa	730.263	-	-	0.6723	0.936
Index	Bursa Malaysia Consumer Products Index	Bursa	1,393.115	-	-	1.7878	1.766
Local Peer	IGBB	Bursa	1,773.791	191.675	-	0.5001	-
Local Peer	BSTEAD	Bursa	1,216.193	-	-	0.3905	-
Local Peer	PHARMA	Bursa	1,067.617	38.847	33.414	2.9821	2.696
Local Peer	KOTRA	Bursa	426.167	17.473	17.473	2.0645	3.124
Local Peer	NOVA	Bursa	276.437	18.991	18.990	2.9422	2.069
Local Peer	SUNZEN	Bursa	123.296	-	-	1.3022	-
Global Peer	JOHNSON & JOHNSON	NYSE	436,333.560	29.654	24.403	-	2.401
Global Peer	PFIZER INC	NYSE	244,227.416	25.398	18.463	3.4869	3.488
Global Peer	ELI LILLY AND COMPANY	NYSE	237,652.984	38.370	39.148	36.8775	1.191
Global Peer	MERCK & CO INC	NYSE	208,205.182	29.462	37.373	6.2535	3.014
Global Peer	NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD)	NYSE	206,536.193	25.587	22.989	3.8218	2.272
Global Peer	ABBVIE INC	NYSE	193,488.538	42.469	29.365	15.3940	4.415
Global Peer	ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS	NASDAQ	192,898.290	60.356	51.153	12.3053	1.865
Global Peer	NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1	NYSE	190,284.316	29.530	26.729	18.2002	1.253
Global Peer	BRISTOL-MYERS SQUIBB CO	NYSE	129,415.686	-	-	3.5160	3.190
Global Peer	SANOFI SPON ADR ECH REP 0.5 ORD SHS	NASDAQ	126,245.922	8.993	18.230	1.6834	-
Other Global Peers	GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), WUXI APPTEC CO LTD (HKEx), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), ROYALTY PHARMA PLC (NASDAQ), VIATRIS INC (NASDAQ), REPLIGEN CORP (NASDAQ), INNOVENT BIOLOGICS INC (HKEx), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), ORGANON & CO (NYSE), CANSINO BIOLOGICS INC (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), SINOPHARM GROUP CO. LTD. (HKEx), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), CUREVAC NV (NASDAQ), REMEGEN CO LTD (HKEx), ALLAKOS INC (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), AKESO INC (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), INNOCARE PHARMA LTD (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), NEKTAR THERAPEUTICS (NASDAQ), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), OPKO HEALTH INC (NASDAQ), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), ADC THERAPEUTICS SA (NYSE), SHANGHAI HENLIUS BIOTECH INC (HKEx), QUANTERIX CORPORATION (NASDAQ), EVEREST MEDICINES LTD (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), DICERNA PHARMACEUTICALS INC. (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), SSY GROUP LIMITED (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), OCUMENSION THERAPEUTICS (HKEx), CSTONE PHARMACEUTICALS (HKEx), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), UNITED LABORATORIES INTL HLDGS LTD (HKEx), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), ZYMEWORKS INC (NYSE), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), IMMUNOTECH BIOPHARM LTD (HKEx), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), ATEA PHARMACEUTICALS INC (NASDAQ), ABBISKO CAYMAN LTD (HKEx), Kimia Farma Tbk. (IDX), PRAXIS PRECISION MEDICINES INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), GOSSAMER BIO INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), KRONOS BIO INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), CK LIFE SCIENCES INTL HLDG (HKEx), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), ANTENGENE CORP LTD (HKEx), CRINETICS PHARMACEUTICALS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), GH RESEARCH PLC (NASDAQ), PETIQ INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), ALIGOS THERAPEUTICS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), ANNEXON INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), VERU INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), TRANSCENTA HOLDING LTD (HKEx), BEYONDSPRING INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), PHARVARIS NV (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), HUA MEDICINE (HKEx), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), Soho Global Health Tbk. (IDX), BOLT BIOTHERAPEUTICS INC (NASDAQ), ZHAOKE OPHTHALMOLOGY LTD (HKEx), CHINOOK THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), EVOLUS INC (NASDAQ), AC IMMUNE SA (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), RACE ONCOLOGY LTD (ASX), 89BIO INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CLENE INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), CLEARSIDE BIOMEDICAL INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), TOT BIOPHARM INTL CO LTD (HKEx), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), CYBIN INC (NYSE American), FUSION PHARMACEUTICALS INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), NEXIMMUNE INC (NASDAQ), ATHENEX INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), XOMA CORP (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), OYSTER POINT PHARMA INC (NASDAQ), FUSEN PHARMACEUTICAL CO LTD (HKEx), DURECT CORP (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), ANNOVIS BIO INC (NYSE American), TRICIDA INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), IMMUNIC INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), OBSEVA SA (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), IP (SET), MUSTANG BIO INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), ALZAMEND NEURO INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), HOOKIPA PHARMA INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), POLYPID LTD (NASDAQ), NOVAN INC (NASDAQ), IX Biopharma (SGX), AYALA PHARMACEUTICALS INC (NASDAQ), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), NEUBASE THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), LOGICBIO THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), NOXOPHARM LTD (ASX), VTV THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), LANTERN PHARMA INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), Merck Tbk. (IDX), EDESA BIOTECH INC (NASDAQ), LANNETT CO INC (NYSE), GENPREX INC (NASDAQ), EYENOVIA INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), MEDIWOUND LTD (NASDAQ), CRESO PHARMA LTD (ASX), IMARA INC (NASDAQ), CHARMACY PHARMACEUTICAL CO LTD (HKEx), YUMANITY THERAPEUTICS INC (NASDAQ), NEW RAY MEDICINE INTL HLDG LTD (HKEx), PROPHASE LABS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), GALECTO INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), Phapros Tbk. (IDX), ELEDON PHARMACEUTICALS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PAK FAH YEOW INTERNATIONAL (HKEx), NEW CENTURY HEALTHCARE HLDGS CO LTD (HKEx), Hyphens Pharma (SGX), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), EXOPHARM LTD (ASX), SYNAPTOGENIX INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), INVION LTD (ASX), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), WAI YUEN TONG MEDICINE HOLDINGS LTD (HKEx), MODERN CHINESE MEDICINE GRP CO LTD (HKEx), SHENZHEN NEPTUNUS INTERLONG BIO-TEC (HKEx), ACURX PHARMACEUTICALS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), RENOVORX INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), BAUDAX BIO INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), PALLA PHARMA LTD (ASX), PURAPHARM CORPORATION LIMITED (HKEx), SEQLL INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), PHARMAXIS (ASX), CNS PHARMACEUTICALS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), XORTX THERAPEUTICS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), JCT (SET), EXTRAWELL PHARMACEUTICAL HLDGS (HKEx), ONCOSIL MEDICAL LIMITED (ASX), TREVI THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), PANBELA THERAPEUTICS INC (NASDAQ), ACRUX (ASX), HOTH THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), IMMURON LIMITED (ASX), PETROS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ISLAND PHARMACEUTICALS LTD (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), TALI DIGITAL LIMITED (ASX), NANJING SINOLIFE UNITED COMPANY LTD (HKEx), AROVELLA THERAPEUTICS LTD (ASX), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PA SHUN INTERNATIONAL HOLDINGS LTD (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)

Notes:

For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
Industry/Index/Peers data is updated daily.
Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

Period		Dividend Received	Capital Appreciation
Short Term Return	5 Days	-	-0.005	-2.44 %
	10 Days	-	-0.010	-4.76 %
	20 Days	-	-0.025	-11.11 %
Medium Term Return	3 Months	-	-0.020	-9.09 %
	6 Months	-	-0.015	-6.98 %
	1 Year	-	-0.044	-18.03 %
Long Term Return	2 Years	-	+0.011	+5.82 %
	3 Years	-	-0.044	-18.03 %
	5 Years	0.002	-0.037	-14.77 %
Annualised Return	Annualised	-	-	-3.15 %

Notes:

Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
Script dividends are ignored in this calculation.

Free Trial

Price Movements

1 Year Range	0.180 - 0.374	Change From 1 Year Low	+0.020	% Change From 1 Year Low (%)	+11.11
1 Year Range	0.180 - 0.374	Change From 1 Year High	-0.174	% Change From 1 Year High (%)	-46.51
2 Years Range	0.065 - 0.394	Change From 2 Years Low	+0.135	% Change From 2 Years Low (%)	+208.64
2 Years Range	0.065 - 0.394	Change From 2 Years High	-0.194	% Change From 2 Years High (%)	-49.21
5 Years Range	0.065 - 0.394	Change From 5 Years Low	+0.135	% Change From 5 Years Low (%)	+208.64
5 Years Range	0.065 - 0.394	Change From 5 Years High	-0.194	% Change From 5 Years High (%)	-49.21

Notes:

Price movements are based on adjusted historical data.

Company Background

IPO Performance

Listing Date	14 Apr 2015			Full Subscription Rate (x)	-
No of Placement Shares (M)	-	No of Public Offer Shares (M)	20.00	Public Offer Subscription Rate (x)	-
IPO Price (MYR)	0.200	First Day Close (MYR)	0.270	First Week Close (MYR)	0.415
Current vs IPO Price (%)	-	First Day Gain (%)	+35.00	First Week Gain (%)	+107.50

Reports Download

Report Type	Financial Year Ended	Download
Annual Report
Annual Report 2018	Dec 2018	Part 1(2.25 MB) Part 2(1.98 MB)
Annual Report 2017	Dec 2017	Part 1(2.33 MB) Part 2(0.51 MB)
Annual Report 2016	Dec 2016	Part 1(2.31 MB) Part 2(2.89 MB)
Annual Report 2015	Dec 2015	Part 1(1.87 MB) Part 2(2.71 MB)
Annual Report 2014	Dec 2014	Part 1(2.18 MB) Part 2(2.21 MB) Part 3(0.08 MB)

Historical Price Data

Date	Open	High	Low	Close	Volume	VWAP
26 Oct 2021	0.200	0.205	0.195	0.205	626,000	0.2008
25 Oct 2021	0.205	0.205	0.195	0.205	890,000	0.2002
22 Oct 2021	0.200	0.205	0.200	0.205	861,800	0.2000
21 Oct 2021	0.200	0.205	0.200	0.200	3,378,000	0.2001
20 Oct 2021	0.205	0.205	0.195	0.205	8,711,000	0.2005
18 Oct 2021	0.205	0.210	0.200	0.205	2,259,300	0.2046
15 Oct 2021	0.205	0.210	0.205	0.205	1,333,200	0.2064
14 Oct 2021	0.205	0.210	0.205	0.205	5,600,300	0.2052
13 Oct 2021	0.210	0.210	0.205	0.205	1,097,300	0.2078
12 Oct 2021	0.210	0.215	0.205	0.210	2,345,100	0.2100
11 Oct 2021	0.210	0.215	0.205	0.210	1,740,300	0.2097
08 Oct 2021	0.205	0.210	0.205	0.210	1,345,100	0.2063
07 Oct 2021	0.210	0.215	0.205	0.205	1,807,300	0.2067
06 Oct 2021	0.210	0.215	0.210	0.215	792,700	0.2107
05 Oct 2021	0.210	0.215	0.210	0.215	2,985,800	0.2101
04 Oct 2021	0.215	0.220	0.210	0.215	2,245,800	0.2152
01 Oct 2021	0.220	0.220	0.215	0.215	2,220,000	0.2156
30 Sep 2021	0.220	0.225	0.220	0.220	2,511,700	0.2202
29 Sep 2021	0.225	0.225	0.220	0.220	1,469,800	0.2203
28 Sep 2021	0.225	0.225	0.220	0.225	2,044,100	0.2249
27 Sep 2021	0.225	0.230	0.220	0.225	2,714,200	0.2247
24 Sep 2021	0.225	0.225	0.220	0.225	2,345,300	0.2217
Summary
Current 2 Weeks (12 Oct 2021 to 26 Oct 2021)	0.210	0.215	0.195	0.205	27,102,000	-
Previous 2 Weeks (28 Sep 2021 to 11 Oct 2021)	0.225	0.225	0.195	0.210	19,162,600	-
4 Weeks from (27 Aug 2021 to 27 Sep 2021)	0.215	0.220	0.195	0.225	144,928,600	-

View All Historical Data

More Information Available

More information is available to our subscribers, including:

Market Moving News from Dow Jones Newswires
Consensus Estimates
Dividend/Distribution History
Financial Summary with Financial Period Comparison
Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
Events Calendar for Results Announcements, Ex-Dates etc
Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

	10 Quick Facts on Food Empire Holdings Limited
	10 answers to the Proposed Merger of ESR-REIT and ARA LOGOS Lo...
	3 Small and Mid Caps Companies with Potential Upside of More t...
	Weekly Market Review – Bitter Feud Being Witnessed in this Edu...

Last (MYR): 0.200	Change: -0.005	High: 0.205	Remarks:
Last (MYR): 0.200	Change (%): -2.44	Low: 0.200	Remarks:
Open	0.200	Yesterday's Close	0.205
Buy Price	0.205	Sell Price	0.200
Buy Volume ('00)	9	Sell Volume ('00)	110
Cumulative Volume ('00)	1,497	Cumulative Value	29,960

Sitemap

Features

Customer Services

Events

Terms of Use

Company News

Price Highlight

Index Highlight

STI

STI Straits Times Index

KLCI FTSE Bursa Malaysia KLCI

HSI Hang Seng Index

SSE SSE Composite Index

N225 Nikkei 225

JCI Jakarta Composite Index

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

Intraday Market Ticker Help

Top Active

Top Gainer

Top Loser

World Indices

Investor-One News

Fundamental - Factsheet

Factsheet

Price Movements:

Fundamental:

Charts:

News:

Others:

Latest News

Key Statistics

Notes:

Peer Comparison

Notes:

Total Shareholder Return

Notes:

Price Movements

Notes:

Company Background

IPO Performance

Reports Download

Historical Price Data

More Information Available

Disclaimer:

SINGAPORE

Malaysia

Thailand